1 Study Coverage 1.1 Drug Closed System Transmission Product Introduction 1.2 Market by Type 1.2.1 Global Drug Closed System Transmission Market Size Growth Rate by Type 1.2.2 Closed Vial Access Device 1.2.3 Closed Syringe Safety Device 1.2.4 Closed Bag/Line Access Device 1.3 Market by Application 1.3.1 Global Drug Closed System Transmission Market Size Growth Rate by Application 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Drug Closed System Transmission Market Size, Estimates and Forecasts 2.1.1 Global Drug Closed System Transmission Revenue 2016-2027 2.1.2 Global Drug Closed System Transmission Sales 2016-2027 2.2 Global Drug Closed System Transmission, Market Size by Region: 2016 VS 2021 VS 2027 2.3 Drug Closed System Transmission Historical Market Size by Region (2016-2021) 2.3.1 Global Drug Closed System Transmission Retrospective Market Scenario in Sales by Region: 2016-2021 2.3.2 Global Drug Closed System Transmission Retrospective Market Scenario in Revenue by Region: 2016-2021 2.4 Drug Closed System Transmission Market Estimates and Projections by Region (2022-2027) 2.4.1 Global Drug Closed System Transmission Sales Forecast by Region (2022-2027) 2.4.2 Global Drug Closed System Transmission Revenue Forecast by Region (2022-2027) 3 Global Drug Closed System Transmission Competitor Landscape by Players 3.1 Global Top Drug Closed System Transmission Manufacturers by Sales 3.1.1 Global Drug Closed System Transmission Sales by Manufacturer (2016-2021) 3.1.2 Global Drug Closed System Transmission Sales Market Share by Manufacturer (2016-2021) 3.2 Global Top Drug Closed System Transmission Manufacturers by Revenue 3.2.1 Key Drug Closed System Transmission Manufacturers Covered: Ranking by Revenue 3.2.2 Global Drug Closed System Transmission Revenue by Manufacturers (2016-2021) 3.2.3 Global Drug Closed System Transmission Revenue Share by Manufacturers (2016-2021) 3.2.4 Global Drug Closed System Transmission Market Concentration Ratio (CR5 and HHI) (2016-2021) 3.2.5 Global Top 10 and Top 5 Companies by Drug Closed System Transmission Revenue in 2020 3.2.6 Global Drug Closed System Transmission Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Global Drug Closed System Transmission Price by Manufacturers 3.4 Global Drug Closed System Transmission Manufacturing Base Distribution, Product Types 3.4.1 Drug Closed System Transmission Manufacturers Manufacturing Base Distribution, Headquarters 3.4.2 Manufacturers Drug Closed System Transmission Product Type 3.4.3 Date of International Manufacturers Enter into Drug Closed System Transmission Market 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2016-2027) 4.1 Global Drug Closed System Transmission Market Size by Type (2016-2021) 4.1.1 Global Drug Closed System Transmission Sales by Type (2016-2021) 4.1.2 Global Drug Closed System Transmission Revenue by Type (2016-2021) 4.1.3 Drug Closed System Transmission Average Selling Price (ASP) by Type (2016-2021) 4.2 Global Drug Closed System Transmission Market Size Forecast by Type (2022-2027) 4.2.1 Global Drug Closed System Transmission Sales Forecast by Type (2022-2027) 4.2.2 Global Drug Closed System Transmission Revenue Forecast by Type (2022-2027) 4.2.3 Drug Closed System Transmission Average Selling Price (ASP) Forecast by Type (2022-2027) 5 Breakdown Data by Application (2016-2027) 5.1 Global Drug Closed System Transmission Market Size by Application (2016-2021) 5.1.1 Global Drug Closed System Transmission Sales by Application (2016-2021) 5.1.2 Global Drug Closed System Transmission Revenue by Application (2016-2021) 5.1.3 Drug Closed System Transmission Price by Application (2016-2021) 5.2 Drug Closed System Transmission Market Size Forecast by Application (2022-2027) 5.2.1 Global Drug Closed System Transmission Sales Forecast by Application (2022-2027) 5.2.2 Global Drug Closed System Transmission Revenue Forecast by Application (2022-2027) 5.2.3 Global Drug Closed System Transmission Price Forecast by Application (2022-2027) 6 China by Players, Type and Application 6.1 China Drug Closed System Transmission Market Size YoY Growth 2016-2027 6.1.1 China Drug Closed System Transmission Sales YoY Growth 2016-2027 6.1.2 China Drug Closed System Transmission Revenue YoY Growth 2016-2027 6.1.3 China Drug Closed System Transmission Market Share in Global Market 2016-2027 6.2 China Drug Closed System Transmission Market Size by Players (International and Local Players) 6.2.1 China Top Drug Closed System Transmission Players by Sales (2016-2021) 6.2.2 China Top Drug Closed System Transmission Players by Revenue (2016-2021) 6.3 China Drug Closed System Transmission Historic Market Review by Type (2016-2021) 6.3.1 China Drug Closed System Transmission Sales Market Share by Type (2016-2021) 6.3.2 China Drug Closed System Transmission Revenue Market Share by Type (2016-2021) 6.3.3 China Drug Closed System Transmission Price by Type (2016-2021) 6.4 China Drug Closed System Transmission Market Estimates and Forecasts by Type (2022-2027) 6.4.1 China Drug Closed System Transmission Sales Forecast by Type (2022-2027) 6.4.2 China Drug Closed System Transmission Revenue Forecast by Type (2022-2027) 6.4.3 China Drug Closed System Transmission Price Forecast by Type (2022-2027) 6.5 China Drug Closed System Transmission Historic Market Review by Application (2016-2021) 6.5.1 China Drug Closed System Transmission Sales Market Share by Application (2016-2021) 6.5.2 China Drug Closed System Transmission Revenue Market Share by Application (2016-2021) 6.5.3 China Drug Closed System Transmission Price by Application (2016-2021) 6.6 China Drug Closed System Transmission Market Estimates and Forecasts by Application (2022-2027) 6.6.1 China Drug Closed System Transmission Sales Forecast by Application (2022-2027) 6.6.2 China Drug Closed System Transmission Revenue Forecast by Application (2022-2027) 6.6.3 China Drug Closed System Transmission Price Forecast by Application (2022-2027) 7 North America 7.1 North America Drug Closed System Transmission Market Size YoY Growth 2016-2027 7.2 North America Drug Closed System Transmission Market Facts & Figures by Country 7.2.1 North America Drug Closed System Transmission Sales by Country (2016-2021) 7.2.2 North America Drug Closed System Transmission Revenue by Country (2016-2021) 7.2.3 U.S. 7.2.4 Canada 8 Asia Pacific 8.1 Asia Pacific Drug Closed System Transmission Market Size YoY Growth 2016-2027 8.2 Asia Pacific Drug Closed System Transmission Market Facts & Figures by Region 8.2.1 Asia Pacific Drug Closed System Transmission Sales by Region (2016-2021) 8.2.2 Asia Pacific Drug Closed System Transmission Revenue by Region (2016-2021) 8.2.3 China 8.2.4 Japan 8.2.5 South Korea 8.2.6 India 8.2.7 Australia 8.2.8 Australia 8.2.9 Indonesia 8.2.10 Thailand 8.2.11 Malaysia 8.2.12 Philippines 8.2.13 Vietnam 9 Europe 9.1 Europe Drug Closed System Transmission Market Size YoY Growth 2016-2027 9.2 Europe Drug Closed System Transmission Market Facts & Figures by Country 9.2.1 Europe Drug Closed System Transmission Sales by Country (2016-2021) 9.2.2 Europe Drug Closed System Transmission Revenue by Country (2016-2021) 9.2.3 Germany 9.2.4 France 9.2.5 U.K. 9.2.6 Italy 10 Latin America 10.1 Latin America Drug Closed System Transmission Market Size YoY Growth 2016-2027 10.2 Latin America Drug Closed System Transmission Market Facts & Figures by Country 10.2.1 Latin America Drug Closed System Transmission Sales by Country (2016-2021) 10.2.2 Latin America Drug Closed System Transmission Revenue by Country (2016-2021) 10.2.3 Mexico 10.2.4 Brazil 10.2.5 Argentina 11 Middle East and Africa 11.1 Middle East and Africa Drug Closed System Transmission Market Size YoY Growth 2016-2027 11.2 Middle East and Africa Drug Closed System Transmission Market Facts & Figures by Country 11.2.1 Middle East and Africa Drug Closed System Transmission Sales by Country (2016-2021) 11.2.2 Middle East and Africa Drug Closed System Transmission Revenue by Country (2016-2021) 11.2.3 Turkey 11.2.4 Saudi Arabia 11.2.5 UAE 12 Company Profiles 12.1 Equashield 12.1.1 Equashield Corporation Information 12.1.2 Equashield Description and Business Overview 12.1.3 Equashield Drug Closed System Transmission Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Equashield Drug Closed System Transmission Products Offered 12.1.5 Equashield Recent Development 12.2 BD Medical 12.2.1 BD Medical Corporation Information 12.2.2 BD Medical Description and Business Overview 12.2.3 BD Medical Drug Closed System Transmission Sales, Revenue and Gross Margin (2016-2021) 12.2.4 BD Medical Drug Closed System Transmission Products Offered 12.2.5 BD Medical Recent Development 12.3 Teva Medical 12.3.1 Teva Medical Corporation Information 12.3.2 Teva Medical Description and Business Overview 12.3.3 Teva Medical Drug Closed System Transmission Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Teva Medical Drug Closed System Transmission Products Offered 12.3.5 Teva Medical Recent Development 12.4 ICU Medical 12.4.1 ICU Medical Corporation Information 12.4.2 ICU Medical Description and Business Overview 12.4.3 ICU Medical Drug Closed System Transmission Sales, Revenue and Gross Margin (2016-2021) 12.4.4 ICU Medical Drug Closed System Transmission Products Offered 12.4.5 ICU Medical Recent Development 12.5 Corvida Medical 12.5.1 Corvida Medical Corporation Information 12.5.2 Corvida Medical Description and Business Overview 12.5.3 Corvida Medical Drug Closed System Transmission Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Corvida Medical Drug Closed System Transmission Products Offered 12.5.5 Corvida Medical Recent Development 12.6 B. Braun 12.6.1 B. Braun Corporation Information 12.6.2 B. Braun Description and Business Overview 12.6.3 B. Braun Drug Closed System Transmission Sales, Revenue and Gross Margin (2016-2021) 12.6.4 B. Braun Drug Closed System Transmission Products Offered 12.6.5 B. Braun Recent Development 12.11 Equashield 12.11.1 Equashield Corporation Information 12.11.2 Equashield Description and Business Overview 12.11.3 Equashield Drug Closed System Transmission Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Equashield Drug Closed System Transmission Products Offered 12.11.5 Equashield Recent Development 13 Market Opportunities, Challenges, Risks and Influences Factors Analysis 13.1 Drug Closed System Transmission Industry Trends 13.2 Drug Closed System Transmission Market Drivers 13.3 Drug Closed System Transmission Market Challenges 13.4 Drug Closed System Transmission Market Restraints 14 Value Chain and Sales Channels Analysis 14.1 Value Chain Analysis 14.2 Drug Closed System Transmission Customers 14.3 Sales Channels Analysis 14.3.1 Sales Channels 14.3.2 Distributors 15 Research Findings and Conclusion 16 Appendix 16.1 Research Methodology 16.1.1 Methodology/Research Approach 16.1.2 Data Source 16.2 Author Details 16.3 Disclaimer

List of Tables Table 1. Global Drug Closed System Transmission Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Closed Vial Access Device Table 3. Major Manufacturers of Closed Syringe Safety Device Table 4. Major Manufacturers of Closed Bag/Line Access Device Table 5. Global Drug Closed System Transmission Market Size Growth Rate by Application (2021-2027) & (K Units) Table 6. Global Drug Closed System Transmission Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027 Table 7. Global Drug Closed System Transmission Sales by Regions (2016-2021) & (K Units) Table 8. Global Drug Closed System Transmission Sales Market Share by Regions (2016-2021) Table 9. Global Drug Closed System Transmission Revenue by Regions (2016-2021) & (US$ Million) Table 10. Global Drug Closed System Transmission Sales Forecast by Region (2022-2027) & (K Units) Table 11. Global Drug Closed System Transmission Sales Market Share Forecast by Region (2022-2027) Table 12. Global Drug Closed System Transmission Revenue Forecast by Region (2022-2027) & (US$ Million) Table 13. Global Drug Closed System Transmission Revenue Market Share Forecast by Region (2022-2027) Table 14. Global Drug Closed System Transmission Sales by Manufacturers (2016-2021) (K Units) Table 15. Global Drug Closed System Transmission Sales Share by Manufacturers (2016-2021) Table 16. Ranking of Global Top Drug Closed System Transmission Manufacturers by Revenue (US$ Million) in 2020 Table 17. Drug Closed System Transmission Revenue by Manufacturers (2016-2021) (US$ Million) Table 18. Drug Closed System Transmission Revenue Share by Manufacturers (2016-2021) Table 19. Global Drug Closed System Transmission Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021) Table 20. Global Drug Closed System Transmission by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Closed System Transmission as of 2020) Table 21. Key Manufacturers Drug Closed System Transmission Price (2016-2021) (US$/Unit) Table 22. Drug Closed System Transmission Manufacturers Manufacturing Base Distribution and Headquarters Table 23. Manufacturers Drug Closed System Transmission Product Type Table 24. Date of International Manufacturers Enter into Drug Closed System Transmission Market Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans Table 26. Global Drug Closed System Transmission Sales by Type (2016-2021) (K Units) Table 27. Global Drug Closed System Transmission Sales Share by Type (2016-2021) Table 28. Global Drug Closed System Transmission Revenue by Type (2016-2021) (US$ Million) Table 29. Global Drug Closed System Transmission Revenue Share by Type (2016-2021) Table 30. Drug Closed System Transmission Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit) Table 31. Global Drug Closed System Transmission Sales Forecast by Type (2022-2027) & (K Units) Table 32. Global Drug Closed System Transmission Sales Market Share Forecast by Type (2022-2027) Table 33. Global Drug Closed System Transmission Revenue Forecast V (2022-2027) & (US$ Million) Table 34. Global Drug Closed System Transmission Revenue Market Share Forecast by Type (2022-2027) Table 35. Global Drug Closed System Transmission Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit) Table 36. Global Drug Closed System Transmission Sales by Application (2016-2021) (K Units) Table 37. Global Drug Closed System Transmission Sales Share by Application (2016-2021) Table 38. Global Drug Closed System Transmission Revenue by Application (2016-2021) (US$ Million) Table 39. Global Drug Closed System Transmission Revenue Share by Application (2016-2021) Table 40. Drug Closed System Transmission Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit) Table 41. Global Drug Closed System Transmission Sales Forecast by Application (2022-2027) & (K Units) Table 42. Global Drug Closed System Transmission Sales Market Share Forecast by Application (2022-2027) Table 43. Global Drug Closed System Transmission Revenue Forecast by Application (2022-2027) & (US$ Million) Table 44. Global Drug Closed System Transmission Revenue Market Share Forecast by Application (2022-2027) Table 45. Global Drug Closed System Transmission Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit) Table 46. China Drug Closed System Transmission Sales (K Units) of Key Companies (2016-2021) Table 47. China Drug Closed System Transmission Sales Share by Company (2016-2021) Table 48. China Drug Closed System Transmission Revenue (US$ Million) by Company (2016-2021) Table 49. China Drug Closed System Transmission Revenue Share by Company (2016-2021) Table 50. China Drug Closed System Transmission Sales (K Units) by Type (2016-2021) Table 51. China Drug Closed System Transmission Sales Share by Type (2016-2021) Table 52. China Drug Closed System Transmission Revenue (US$ Million) Market Share by Type (2016-2021) Table 53. China Drug Closed System Transmission Price (US$/Unit) by Type (2016-2021) Table 54. China Drug Closed System Transmission Sales (K Units) by Type (2022-2027) Table 55. China Drug Closed System Transmission Sales Share by Type (2022-2027) Table 56. China Drug Closed System Transmission Revenue (US$ Million) Market Share by Type (2022-2027) Table 57. China Drug Closed System Transmission Revenue Share by Type (2022-2027) Table 58. China Drug Closed System Transmission Price (US$/Unit) by Type (2022-2027) Table 59. China Drug Closed System Transmission Sales (K Units) by Application (2016-2021) Table 60. China Drug Closed System Transmission Sales Share by Application (2016-2021) Table 61. China Drug Closed System Transmission Revenue (US$ Million) Market Share by Application (2016-2021) Table 62. China Drug Closed System Transmission Price (US$/Unit) by Application (2016-2021) Table 63. China Drug Closed System Transmission Sales (K Units) by Application (2022-2027) Table 64. China Drug Closed System Transmission Sales Share by Application (2022-2027) Table 65. China Drug Closed System Transmission Revenue (US$ Million) Market Share by Application (2022-2027) Table 66. China Drug Closed System Transmission Revenue Share by Application (2022-2027) Table 67. China Drug Closed System Transmission Price (US$/Unit) by Application (2022-2027) Table 68. North America Drug Closed System Transmission Sales by Country (2016-2021) & (K Units) Table 69. North America Drug Closed System Transmission Sales Market Share by Country (2016-2021) Table 70. North America Drug Closed System Transmission Revenue by Country (2016-2021) & (US$ Million) Table 71. North America Drug Closed System Transmission Revenue Market Share by Country (2016-2021) Table 72. Asia Pacific Drug Closed System Transmission Sales by Region (2016-2021) & (K Units) Table 73. Asia Pacific Drug Closed System Transmission Sales Market Share by Region (2016-2021) Table 74. Asia Pacific Drug Closed System Transmission Revenue by Region (2016-2021) & (US$ Million) Table 75. Asia Pacific Drug Closed System Transmission Revenue Market Share by Region (2016-2021) Table 76. Europe Drug Closed System Transmission Sales by Country (2016-2021) & (K Units) Table 77. Europe Drug Closed System Transmission Sales Market Share by Country (2016-2021) Table 78. Europe Drug Closed System Transmission Revenue by Country (2016-2021) & (US$ Million) Table 79. Europe Drug Closed System Transmission Revenue Market Share by Country (2016-2021) Table 80. Latin America Drug Closed System Transmission Sales by Country (2016-2021) & (K Units) Table 81. Latin America Drug Closed System Transmission Sales Market Share by Country (2016-2021) Table 82. Latin Americaa Drug Closed System Transmission Revenue by Country (2016-2021) & (US$ Million) Table 83. Latin America Drug Closed System Transmission Revenue Market Share by Country (2016-2021) Table 84. Middle East and Africa Drug Closed System Transmission Sales by Country (2016-2021) & (K Units) Table 85. Middle East and Africa Drug Closed System Transmission Sales Market Share by Country (2016-2021) Table 86. Middle East and Africa Drug Closed System Transmission Revenue by Country (2016-2021) & (US$ Million) Table 87. Middle East and Africa Drug Closed System Transmission Revenue Market Share by Country (2016-2021) Table 88. Equashield Corporation Information Table 89. Equashield Description and Business Overview Table 90. Equashield Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 91. Equashield Drug Closed System Transmission Product Table 92. Equashield Recent Development Table 93. BD Medical Corporation Information Table 94. BD Medical Description and Business Overview Table 95. BD Medical Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 96. BD Medical Product Table 97. BD Medical Recent Development Table 98. Teva Medical Corporation Information Table 99. Teva Medical Description and Business Overview Table 100. Teva Medical Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 101. Teva Medical Product Table 102. Teva Medical Recent Development Table 103. ICU Medical Corporation Information Table 104. ICU Medical Description and Business Overview Table 105. ICU Medical Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 106. ICU Medical Product Table 107. ICU Medical Recent Development Table 108. Corvida Medical Corporation Information Table 109. Corvida Medical Description and Business Overview Table 110. Corvida Medical Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 111. Corvida Medical Product Table 112. Corvida Medical Recent Development Table 113. B. Braun Corporation Information Table 114. B. Braun Description and Business Overview Table 115. B. Braun Drug Closed System Transmission Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021) Table 116. B. Braun Product Table 117. B. Braun Recent Development Table 118. Drug Closed System Transmission Market Trends Table 119. Drug Closed System Transmission Market Drivers Table 120. Drug Closed System Transmission Market Challenges Table 121. Drug Closed System Transmission Market Restraints Table 122. Drug Closed System Transmission Customers List Table 123. Drug Closed System Transmission Distributors List Table 124. Research Programs/Design for This Report Table 125. Key Data Information from Secondary Sources Table 126. Key Data Information from Primary Sources List of Figures Figure 1. Drug Closed System Transmission Product Picture Figure 2. Global Drug Closed System Transmission Sales Market Share by Type in 2020 & 2027 Figure 3. Closed Vial Access Device Product Picture Figure 4. Closed Syringe Safety Device Product Picture Figure 5. Closed Bag/Line Access Device Product Picture Figure 6. Global Drug Closed System Transmission Sales Market Share by Application in 2020 & 2027 Figure 7. Hospital Figure 8. Clinic Figure 9. Other Figure 10. Drug Closed System Transmission Report Years Considered Figure 11. Global Drug Closed System Transmission Market Size, (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Drug Closed System Transmission Market Size 2016-2027 (US$ Million) Figure 13. Global Drug Closed System Transmission Sales 2016-2027 (K Units) Figure 14. Global Drug Closed System Transmission Market Size Market Share by Region: 2021 Versus 2027 Figure 15. Global Drug Closed System Transmission Sales Market Share by Region (2016-2021) Figure 16. Global Drug Closed System Transmission Sales Market Share by Region in 2020 Figure 17. Global Drug Closed System Transmission Revenue Market Share by Region (2016-2021) Figure 18. Global Drug Closed System Transmission Revenue Market Share by Region in 2020 Figure 19. Global Drug Closed System Transmission Sales Share by Manufacturer in 2020 Figure 20. The Top 10 and 5 Players Market Share by Drug Closed System Transmission Revenue in 2020 Figure 21. Drug Closed System Transmission Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 22. Global Drug Closed System Transmission Sales Market Share by Type (2016-2021) Figure 23. Global Drug Closed System Transmission Sales Market Share by Type in 2020 Figure 24. Global Drug Closed System Transmission Revenue Market Share by Type (2016-2021) Figure 25. Global Drug Closed System Transmission Revenue Market Share by Type in 2020 Figure 26. Global Drug Closed System Transmission Sales Market Share by Application (2016-2021) Figure 27. Global Drug Closed System Transmission Sales Market Share by Application in 2020 Figure 28. Global Drug Closed System Transmission Revenue Market Share by Application (2016-2021) Figure 29. Global Drug Closed System Transmission Revenue Market Share by Application in 2020 Figure 30. China Drug Closed System Transmission Sales Growth Rate 2016-2027 (K Units) Figure 31. China Drug Closed System Transmission Revenue Growth Rate 2016-2027 (US$ Million) Figure 32. China Drug Closed System Transmission Market Share in Global Market 2016-2027 Figure 33. China 5 and 10 Largest Drug Closed System Transmission Players Market Share by Revenue in Drug Closed System Transmission in 2020 Figure 34. China Drug Closed System Transmission Revenue Share by Type (2016-2021) Figure 35. China Drug Closed System Transmission Revenue Growth Rate by Type in 2016 & 2020 Figure 36. China Drug Closed System Transmission Revenue Share by Application (2016-2021) Figure 37. China Drug Closed System Transmission Revenue Growth Rate by Application in 2016 & 2020 Figure 38. North America Drug Closed System Transmission Sales Growth Rate 2016-2021 (K Units) Figure 39. North America Drug Closed System Transmission Revenue Growth Rate 2016-2021 (US$ Million) Figure 40. North America Drug Closed System Transmission Sales Market Share by Country in 2020 Figure 41. North America Drug Closed System Transmission Revenue Market Share by Country in 2020 Figure 42. U.S. Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 43. U.S. Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Canada Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 45. Canada Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Europe Drug Closed System Transmission Sales Growth Rate 2016-2021 (K Units) Figure 47. Europe Drug Closed System Transmission Revenue Growth Rate 2016-2021 (US$ Million) Figure 48. Europe Drug Closed System Transmission Sales Market Share by Country in 2020 Figure 49. Europe Drug Closed System Transmission Revenue Market Share by Country in 2020 Figure 50. Germany Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 51. Germany Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 52. France Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 53. France Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 54. U.K. Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 55. U.K. Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 56. Italy Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 57. Italy Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 58. Russia Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 59. Russia Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 60. Asia Pacific Drug Closed System Transmission Sales Growth Rate 2016-2021 (K Units) Figure 61. Asia Pacific Drug Closed System Transmission Revenue Growth Rate 2016-2021 (US$ Million) Figure 62. Asia Pacific Drug Closed System Transmission Sales Market Share by Region in 2020 Figure 63. Asia Pacific Drug Closed System Transmission Revenue Market Share by Region in 2020 Figure 64. China Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 65. China Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 66. Japan Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 67. Japan Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 68. South Korea Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 69. South Korea Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 70. India Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 71. India Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 72. Australia Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 73. Australia Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 74. Taiwan Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 75. Taiwan Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 76. Indonesia Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 77. Indonesia Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 78. Thailand Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 79. Thailand Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 80. Malaysia Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 81. Malaysia Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 82. Philippines Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 83. Philippines Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 84. Vietnam Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 85. Vietnam Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 86. Latin America Drug Closed System Transmission Sales Growth Rate 2016-2021 (K Units) Figure 87. Latin America Drug Closed System Transmission Revenue Growth Rate 2016-2021 (US$ Million) Figure 88. Latin America Drug Closed System Transmission Sales Market Share by Country in 2020 Figure 89. Latin America Drug Closed System Transmission Revenue Market Share by Country in 2020 Figure 90. Mexico Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 91. Mexico Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 92. Brazil Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 93. Brazil Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 94. Argentina Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 95. Argentina Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 96. Middle East and Africa Drug Closed System Transmission Sales Growth Rate 2016-2021 (K Units) Figure 97. Middle East and Africa Drug Closed System Transmission Revenue Growth Rate 2016-2021 (US$ Million) Figure 98. Middle East and Africa Drug Closed System Transmission Sales Market Share by Country in 2020 Figure 99. Middle East and Africa Drug Closed System Transmission Revenue Market Share by Country in 2020 Figure 100. Turkey Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 101. Turkey Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 102. Saudi Arabia Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 103. Saudi Arabia Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 104. UAE Drug Closed System Transmission Sales Growth Rate (2016-2021) (K Units) Figure 105. UAE Drug Closed System Transmission Revenue Growth Rate (2016-2021) (US$ Million) Figure 106. Drug Closed System Transmission Value Chain Figure 107. Channels of Distribution Figure 108. Distributors Profiles Figure 109. Bottom-up and Top-down Approaches for This Report Figure 110. Data Triangulation Figure 111. Key Executives Interviewed

Equashield BD Medical Teva Medical ICU Medical Corvida Medical B. Braun